Global Pharmatech, Inc. engages in the discovery, development, manufacture, and marketing of proprietary drugs developed based on traditional Chinese medicine. The company is headquartered in Changchun, Jilin and currently employs 217 full-time employees. The company went IPO on 2006-05-12. The Company’s main patented products include JUTAI SOFT CAPSULE, QINGXUAN ANTI-HYPERTENSION TABLET, YANREQING TABLET. The firm is also engaged in the manufacture and sales of other proprietary drugs, generics and dietary supplements used to treat symptoms ranging from headaches, coughing and dry mouth to infections and numbness of limbs. The firm also engages in the provision of biotechnology services, including research and development, testing, manufacturing drugs in liquid and solid dose forms, sales and marketing. The firm conducts its business in the domestic and overseas markets.
Follow-Up Questions
¿Qué tal es el rendimiento del precio de la acción GBLP?
El precio actual de GBLP es de $0, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Global Pharmatech Inc?
Global Pharmatech Inc pertenece a la industria Consumer products y el sector es Consumer Staples
¿Cuál es la capitalización bursátil de Global Pharmatech Inc?
La capitalización bursátil actual de Global Pharmatech Inc es $0
